Neuland Laboratories Ltd. (NEULANDLAB) Share Price Hits 52-Week High

Neuland Laboratories Ltd. Share Price reached Rs 21,235.85, up 6.37% today, marking a fresh 52-week high. The market capitalisation stands at Rs 24,746.74 crore.

Neuland Laboratories Ltd. Share Price surged to Rs 21,235.85 today, reflecting a 6.37% increase from the previous close of Rs 19,964.7. This rise marks a fresh 52-week high for the company, with the stock reaching an intraday high of Rs 21,850. The market capitalisation of Neuland Laboratories Ltd. now stands at Rs 24,746.74 crore. This significant price movement has captured the attention of investors and analysts alike, as the stock continues to show strong momentum in the market.

Neuland Laboratories Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 21,235.85
Previous Close	Rs 19,964.7
Today's Change	+Rs 1,271.15 (+6.37%)
Day Open	Rs 21,270.1
Fresh 52-Week High	Rs 21,850
Day Low	Rs 20,972.65
Current Volume	12,229
Turnover	Rs 25.97 crore
Market Capitalisation	Rs 24,746.74 crore

Neuland Laboratories Ltd. (NEULANDLAB) traded at Rs 21,235.85. versus the previous close of Rs 19,964.7, a rise of 6.37%. The stock opened at Rs 21,270.1, reached Rs 21,850, touched Rs 20,972.65. Reported volume was 12,229.

Today, Neuland Laboratories Ltd. opened at Rs 21,270.1 and reached a high of Rs 21,850, setting a new 52-week peak. The stock closed at Rs 21,235.85, up by Rs 1,271.15 or 6.37% from the previous close. The day's low was Rs 20,972.65, with a turnover of Rs 25.97 crore. The current volume of 12,229 shares indicates active trading, as the stock continues to attract investor interest.

Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 24,746.74 crore
P/E Ratio	31.4x
P/B Ratio	0.46x
ROE	-2.89%
ROCE	-0.26%

Neuland Laboratories Ltd. was valued at a P/E ratio of 31.4x, a P/B ratio of 0.46x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	31.4x
Benchmark Median P/E	21.61x
Benchmark Average P/E	72.01x
Benchmark P/E Range	0x to 3,428.55x
Company P/B Ratio	0.46x
Benchmark Median P/B	1.92x
Company ROE	-2.89%
Benchmark Median ROE	10.75%
Company ROCE	-0.26%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 24,746.74 crore
Benchmark Median Market Cap	Rs 139.72 crore

Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare.

Neuland Laboratories Ltd. (NEULANDLAB) has a P/E ratio of 31.4x, which is above the benchmark median of 21.61x, a difference of +45.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Neuland Laboratories Ltd. (NEULANDLAB) has a ROE of -2.89%, which is below the benchmark median of 10.75%, a difference of -126.88%. Neuland Laboratories Ltd. (NEULANDLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,943.6	31.4	0.46	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,684.11	39.39	8.02	28.21	26.35
Beta Drugs Ltd.	BETA	2,621.81	63.25	10.01	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,511.89	32.96	6.79	-2.6	16.92
Sai Parenteral's Ltd.	SAIPARENT	2,347.02	160.63	2.97	13.9	12.97

Neuland Laboratories Ltd. (NEULANDLAB) has a P/E ratio of 31.4x compared with the displayed peer median of 39.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 24,746.74 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Neuland Laboratories Ltd.

• Neuland Laboratories Ltd. Share Price hit a fresh 52-week high, indicating strong market interest.
• The stock's P/B ratio suggests potential undervaluation compared to sector peers.
• Negative ROE and ROCE may concern investors about profitability.
• Significant market capitalisation positions the company as a key player in the Healthcare sector.

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. operates in the Healthcare sector, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs). The company serves a global clientele, providing high-quality APIs for various therapeutic segments. With a strong emphasis on research and development, Neuland Laboratories Ltd. continues to innovate and expand its product portfolio, catering to the evolving needs of the pharmaceutical industry.

Track Neuland Laboratories Ltd. Share Price on Univest

Use Neuland Laboratories Ltd. (NEULANDLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Neuland Laboratories Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest for comprehensive analysis and informed decision-making.

Frequently Asked Questions

What is the current share price of Neuland Laboratories Ltd.?

Ans. The current share price of Neuland Laboratories Ltd. is Rs 21,235.85, marking a 6.37% increase from the previous close. The stock moved 6.37% during the session. The intraday range extended from Rs 20,972.65 to Rs 21,850.

What is the 52-week high of Neuland Laboratories Ltd.?

Ans. Neuland Laboratories Ltd. reached a 52-week high of Rs 21,850 today, reflecting strong market momentum. The stock moved 6.37% during the session. The intraday range extended from Rs 20,972.65 to Rs 21,850.

How does Neuland Laboratories Ltd.'s P/E ratio compare to the sector?

Ans. Neuland Laboratories Ltd.'s P/E ratio of 31.4 aligns with the sector median of 21.61, indicating a competitive valuation. The company trades at a P/E ratio of 31.4x. Its P/B ratio is 0.46x.

What are the ROE and ROCE of Neuland Laboratories Ltd.?

Ans. Neuland Laboratories Ltd. has a negative ROE of -2.89% and ROCE of -0.26%, highlighting profitability challenges. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.75%.

What is the market capitalisation of Neuland Laboratories Ltd.?

Ans. The market capitalisation of Neuland Laboratories Ltd. is Rs 24,746.74 crore, positioning it as a major player in the Healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 31.4x.

How does Neuland Laboratories Ltd.'s P/B ratio compare to peers?

Ans. Neuland Laboratories Ltd.'s P/B ratio of 0.46 is lower than its peers, suggesting a potentially undervalued position. The company trades at a P/E ratio of 31.4x. Its P/B ratio is 0.46x.

Who are the key peers of Neuland Laboratories Ltd.?

Ans. Key peers include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Beta Drugs Ltd., among others. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd.

What is the significance of Neuland Laboratories Ltd.'s 52-week high?

Ans. The 52-week high signifies strong market interest and momentum in Neuland Laboratories Ltd.'s stock. The stock moved 6.37% during the session. The intraday range extended from Rs 20,972.65 to Rs 21,850.